Literature DB >> 1511409

Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines.

S Taniguchi1, H Fujiki, H Kobayashi, H Go, K Miyado, H Sadano, R Shimokawa.   

Abstract

(-)-Epigallocatechin gallate (EGCG), the main polyphenolic constituent of green tea, inhibits tumor promotion and chemical carcinogenesis in animal experimental systems. Here we report that the peroral administration of EGCG inhibited metastasis of B16 melanoma cell lines, such as B16-F10 and BL6, in both experimental and spontaneous systems.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1511409     DOI： 10.1016/0304-3835(92)90212-e

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


  52 in total

1.  Rapid microtiter assays for poxvirus topoisomerase, mammalian type IB topoisomerase and HIV-1 integrase: application to inhibitor isolation.

Authors:  Y Hwang; D Rhodes; F Bushman
Journal:  Nucleic Acids Res       Date:  2000-12-15       Impact factor: 16.971

2.  Assay systems for screening food components that have anti-proliferative and anti-invasive activity to rat ascites hepatoma cells: In vitro and ex vivo effects of green tea extract.

Authors:  Y Miura; H Shiomi; F Sakai; K Yagasaki
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

3.  Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy.

Authors:  G Zhang; Y Wang; Y Zhang; X Wan; J Li; K Liu; F Wang; K Liu; Q Liu; C Yang; P Yu; Y Huang; S Wang; P Jiang; Z Qu; J Luan; H Duan; L Zhang; A Hou; S Jin; T-C Hsieh; E Wu
Journal:  Curr Mol Med       Date:  2012-02       Impact factor: 2.222

Review 4.  Unconventional therapies for cancer: 2. Green tea. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-04-21       Impact factor: 8.262

5.  Clinical effect of locally delivered gel containing green tea extract as an adjunct to non-surgical periodontal treatment.

Authors:  Kanyawat Rattanasuwan; Supanee Rassameemasmaung; Vanida Sangalungkarn; Chulaluk Komoltri
Journal:  Odontology       Date:  2014-12-19       Impact factor: 2.634

Review 6.  Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.

Authors:  Y D Jung; L M Ellis
Journal:  Int J Exp Pathol       Date:  2001-12       Impact factor: 1.925

7.  Inhibition of 7,12-dimethylbenzanthracene-induced skin tumors by a nutrient mixture.

Authors:  M W Roomi; N W Roomi; T Kalinovsky; V Ivanov; M Rath; A Niedzwiecki
Journal:  Med Oncol       Date:  2008-01-18       Impact factor: 3.064

8.  Inhibitory effect of tea polyphenols on histamine and leukotriene B4 release from rat peritoneal exudate cells.

Authors:  N Matsuo; K Yamada; K Yamashita; K Shoji; M Mori; M Sugano
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-06       Impact factor: 2.416

Review 9.  Micronutrient synergy--a new tool in effective control of metastasis and other key mechanisms of cancer.

Authors:  A Niedzwiecki; M W Roomi; T Kalinovsky; M Rath
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

Review 10.  Emerging phytochemicals for prevention of melanoma invasion.

Authors:  Virginia Jones; Santosh K Katiyar
Journal:  Cancer Lett       Date:  2013-03-06       Impact factor: 8.679
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.